Concepedia

Yan Xing

YX

Statistics

Publications

22

Citations

2.3K

H-Index

18

Active since

2001

Affiliations

Principia Biopharma (United States)(Current)

University of Minnesota

Kumamoto University

University of Minnesota Medical Center

Nanjing Medical University

Yan Xing is an author at Principia Biopharma (United States) specializing in life sciences, immunology, and molecular biology.

ORCID

Publications per year

2001–2023

22

Publications

22

T cell receptor signal strength in Treg and iNKT cell development demonstrated by a novel fluorescent reporter mouse

Amy E. Moran, Keli L. Holzapfel, Yan Xing et al. · The Journal of Experimental Medicine · 2011 · 1K citations · Full text

, , +17

Costimulation via the tumor-necrosis factor receptor superfamily couples TCR signal strength to the thymic differentiation of regulatory T cells

Shawn A. Mahmud, Luke S. Manlove, Heather Schmitz et al. · Nature Immunology · 2014 · 273 citations · Full text

, , +14

Late stages of T cell maturation in the thymus involve NF-κB and tonic type I interferon signaling

Yan Xing, Xiaodan Wang, Stephen C. Jameson et al. · Nature Immunology · 2016 · 203 citations

, , +13

Preclinical Efficacy and Anti-Inflammatory Mechanisms of Action of the Bruton Tyrosine Kinase Inhibitor Rilzabrutinib for Immune-Mediated Disease

Claire L. Langrish, J. Michael Bradshaw, Michelle Francesco et al. · The Journal of Immunology · 2021 · 124 citations · Full text

, , +17

Discovery of Reversible Covalent Bruton’s Tyrosine Kinase Inhibitors PRN473 and PRN1008 (Rilzabrutinib)

Timothy D. Owens, Ken A. Brameld, Erik Verner et al. · Journal of Medicinal Chemistry · 2022 · 78 citations · Full text

, , +15

1–5 of 22